8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Merck & Co., Inc. (MRK)

Merck ($MRK) furnished a press release on Feb 3, 2026 with Q4 & FY2025 earnings; Exhibits 99.1 (press…

Filed with the SEC on · Summarized by InvestorsBot

Merck ($MRK) furnished a press release on Feb 3, 2026 with Q4 & FY2025 earnings; Exhibits 99.1 (press release) and 99.2 (supplemental info) attached. Review the release and supplemental data for full results. 📊🧾 #earnings #pharma

Disclosure: The Feb 3, 2026 earnings materials were furnished, not filed under Item 2.02 — not subject to Section 18 liabilities and not incorporated by reference into other SEC filings unless expressly stated. ⚖️ $MRK #SEC #disclosure

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from Merck & Co., Inc.

Merck ($MRK) filed an 8‑K on Feb 3, 2026 furnishing a press release (Exh.99.1) with Q4 & FY2025 earnings.

8-K · February 3, 2026